Changeflow GovPing Pharma & Drug Safety MEDTIDE Trademark Application
Routine Notice Added Final

MEDTIDE Trademark Application

Favicon for changeflow.com ChangeBridge: Trademarks - Pharmaceuticals (Class 005)
Published March 31st, 2026
Detected April 1st, 2026
Email

Summary

USPTO received an Intent to Use trademark application (TM99057317) for MEDTIDE filed by an unidentified applicant on March 31, 2026. The application covers International Class 005, encompassing pharmaceutical preparations, biopharmaceuticals, diagnostic preparations, chemical compounds for pharmaceutical manufacturing, and medical/therapeutic treatments. No compliance obligations arise from this filing; it represents a standard trademark registration record.

What changed

USPTO recorded an Intent to Use application TM99057317 for the word mark MEDTIDE on March 31, 2026. The application encompasses 47 distinct goods and services descriptions across Class 005 (pharmaceuticals) and related scientific research, chemical manufacturing, and business consultancy services. Key covered goods include peptide and protein compounds, anti-cancer and anti-diabetic preparations, biopharmaceuticals, diagnostic biomarkers, and drug delivery systems.

No action is required from regulated entities. This is a trademark filing record, not a regulatory requirement. Companies operating in pharmaceutical manufacturing, biotechnology, or diagnostics who may have conflicting trademarks in Class 005 may wish to monitor this application through the USPTO opposition period. The Intent to Use basis indicates the applicant has not yet used the mark in commerce but intends to do so.

Source document (simplified)

← USPTO Trademark Applications

MEDTIDE

Intent to Use TM99057317 Kind: intenttouse Mar 31, 2026

Abstract

Scientific and chemical research; chemical engineering; product research and development for the pharmaceutical industry; research and development services in the field of chemistry, peptides, proteins, and oligonucleotides; research and development services in the field of pharmaceutical preparations and biochemistry, cosmetics and diagnostic preparations; research in the fields of chemistry and biology; development of production methods for peptides, proteins, oligonucleotides and cosmetics; research in the field of recombinant DNA technology; scientific analysis, namely, analytical method development for peptides, proteins, oligonucleotides, pharmaceuticals and cosmetics; scientific laboratory services; chemical analysis; chemical, biochemical, biological and bacteriological research and analysis; analysis in the form of research in the field of molecular biology; conduct scientific feasibility studies; provide scientific research report preparation; quality control for others; product testing; scientific and technology consultancy in the fields of material testing, biochemistry, and chemistry industries, and laboratory testing research; Financial consultancy in the fields of material testing, biochemistry, chemistry and science industries, and laboratory testing research; Chemicals, chemical preparations and chemical reagents for use in industry and science; chemical compounds, namely, peptides, proteins, and oligonucleotides for use in industry and science; chemical compounds, namely, oligopeptides for industrial use; chemical compounds, namely, proteins for use in manufacture; amino acids for industrial and scientific use; peptide substrates for scientific use; chemical preparations, peptides, oligonucleotides being chemical compounds and proteins for use in the manufacture of cosmetics; chemical preparations for use in the production of medicines and in the manufacture of pharmaceuticals; chemical compounds, namely, peptides, proteins, and oligonucleotides for use in the manufacture of pharmaceuticals; chemicals for use in biotechnological manufacturing processes and in biotechnological product development; active chemical ingredients for use in the manufacture of anti-cancer drugs, anti-diabetes drugs, drugs against metabolic diseases, drugs for wound healing, drugs against genetic diseases, and drugs against neurological diseases; diagnostic preparations and diagnostic reagents for scientific or research use; biochemical preparations for scientific use; Business consultancy in the fields of material testing, biochemistry, chemistry and science industries, and laboratory testing research; Chemical reagents, diagnostic preparations and diagnostic test reagents for medical and veterinary use; peptides, oligonucleotides and amino acids for medical, pharmaceutical and veterinary use, in treating infectious diseases, metabolic diseases and cancer; protein arrays for diagnostic use; biological and pharmaceutical preparations, peptides, proteins, and oligonucleotides for diagnostic purposes; diagnostic kits containing diagnostic agents, preparations and substances for medical use; pharmaceutical preparations for use against metabolic, genetic, neurological diseases and for wound healing; anti-bacterial preparations for medical purposes; anti-cancer and anti-diabetic preparations; antitumor drugs; biopharmaceutical anti-tumor medicines; biopharmaceuticals for cancer treatments; chemotherapeutics; cosmeceuticals being pharmaceutical products for therapeutic and medical use in treating infectious diseases, metabolic diseases and cancer; dermatological preparations; diagnostic biomarker reagents for medical use; food supplements with cosmetic effect; dietetic preparations adapted for medical and veterinary uses; drug delivery agents in the form of tablet coatings that facilitate pharmaceutical preparation delivery; in vitro diagnostic preparations for medical use; Custom manufacture of pharmaceuticals; custom manufacture of bi...

Filing Date

2025-02-26

View original document →

Classification

Agency
USPTO
Published
March 31st, 2026
Instrument
Notice
Legal weight
Non-binding
Stage
Final
Change scope
Minor
Document ID
TM99057317

Who this affects

Applies to
Pharmaceutical companies Drug manufacturers Investors
Industry sector
3254 Pharmaceutical Manufacturing
Activity scope
Trademark Registration
Geographic scope
United States US

Taxonomy

Primary area
Intellectual Property
Operational domain
Legal
Topics
Pharmaceuticals Consumer Protection

Get Pharma & Drug Safety alerts

Weekly digest. AI-summarized, no noise.

Free. Unsubscribe anytime.

Get alerts for this source

We'll email you when ChangeBridge: Trademarks - Pharmaceuticals (Class 005) publishes new changes.

Optional. Personalizes your daily digest.

Free. Unsubscribe anytime.